Prospective surveillance of antiviral resistance in hospitalized infants less than 12 months of age with A(H3N2) influenza infection and treated with oseltamivir.

Rath, Barbara; Chen, Xi; Spies, Vera; Muehlhans, Susann; Obermeier, Patrick; Tief, Franziska; Seeber, Lea; Karsch, Katharina; Milde, Jeanette; Skopnik, Heino; Schweiger, Brunhilde; Duwe, Susanne C

Rath, Barbara; Chen, Xi; Spies, Vera; Muehlhans, Susann; Obermeier, Patrick; Tief, Franziska; Seeber, Lea; Karsch, Katharina; Milde, Jeanette; Skopnik, Heino; Schweiger, Brunhilde; Duwe, Susanne C.

Afiliação

Rath B; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Chen X; Vienna Vaccine Safety Initiative, Berlin, Germany.
Spies V; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Muehlhans S; Klinikum Worms, Department of Pediatrics and Adolescent Medicine, Worms, Germany.
Obermeier P; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Tief F; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Seeber L; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Karsch K; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Milde J; Charité University Medical Center, Department of Pediatrics, Berlin, Germany.
Skopnik H; Robert Koch Institute, Division of Influenza Viruses and Other Respiratory Viruses, National Reference Centre for Influenza, Berlin, Germany.
Schweiger B; Klinikum Worms, Department of Pediatrics and Adolescent Medicine, Worms, Germany.
Duwe SC; Robert Koch Institute, Division of Influenza Viruses and Other Respiratory Viruses, National Reference Centre for Influenza, Berlin, Germany.

Antivir Ther ; 22(6): 515-522, 2017.

Article em En | MEDLINE | ID: mdl-28205506

Assuntos

Farmacorresistência Viral; Hospitalização; Vírus da Influenza A Subtipo H3N2/efeitos dos fármacos; Influenza Humana/tratamento farmacológico; Influenza Humana/virologia; Oseltamivir/farmacologia; Oseltamivir/uso terapêutico; Antivirais/uso terapêutico; Inibidores Enzimáticos/uso terapêutico; Feminino; Humanos; Lactente; Recém-Nascido; Vírus da Influenza A Subtipo H3N2/genética; Influenza Humana/diagnóstico; Influenza Humana/epidemiologia; Masculino; Testes de Sensibilidade Microbiana; Neuraminidase/antagonistas & inibidores; Vigilância em Saúde Pública; RNA Viral; Carga Viral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacorresistência Viral / Influenza Humana / Vírus da Influenza A Subtipo H3N2 / Oseltamivir / Hospitalização Tipo de estudo: Diagnostic_studies / Risk_factors_studies / Screening_studies Limite: Female / Humans / Infant / Male / Newborn Idioma: En Revista: Antivir Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google